Main Topic Area
All Topic Areas
1 - 10 of 1104 more >>
Articles
1 - 1 of 1
- Antagon Injection Consumer Information
Antagon is used to inhibit premature ovulation in women undergoing fertility procedures. Women who have experienced a hypersensitivity reaction to gonadotropin-releasing hormone (GnRH) or any other GnRH-type drug. Women who suspect or know they are pregnant. A physician specializing in fertility treatment should prescribe Antagon. Before starting treatment with Antagon, pregnancy must be ruled out. General Precautions with Antagon: Patients with hypersensitivity to GnRH should be closely...
U.S. Food and Drug Administration
News
1 - 5 of 396 more >>
- FDA Grants Priority Review To Lovenox® (Enoxaparin Sodium Injection) Supplemental New Drug Application (sNDA) For Additional Type Of Heart Attack
MedicalNewsToday - Mon, 12 Feb 2007 08:00 EST
- FDA Grants Priority Review To Lovenox(R) (Enoxaparin Sodium Injection) Supplemental New Drug Application (sNDA) For Acute Heart Attack
MedicalNewsToday - Thu, 08 Feb 2007 08:00 EST
- GlaxoSmithKline Receives Approvable Letter For New Indications For ARIXTRA(R) (Fondaparinux Sodium) Injection
MedicalNewsToday - Sat, 03 Feb 2007 08:00 EST
- Phase 2 Results Of Genasense(R) Plus Chemotherapy In Advanced Prostate Cancer Reported At Cancer Conference
MedicalNewsToday - Sat, 24 Feb 2007 08:00 EST
- Injection Drug Use Fueling Spread Of HIV In Mauritius
MedicalNewsToday - Mon, 26 Feb 2007 09:00 EST
Clinical Trials
1 - 5 of 636 more >>
- Pegaptanib Sodium (Macugen) Compared to Sham Injection in Patients with Diabetic Macular Edema (DME) Involving the Center of the Macula
ClinicalTrials.gov Identifier: NCT00148811 - Active, not recruiting
Diabetic Macular Edema
- ATX-101 (Sodium Deoxycholate for Injection) for the Treatment of Superficial Lipomas
ClinicalTrials.gov Identifier: NCT00422188 - Recruiting
Lipoma
- A Study to Assess the Effect of Montelukast Sodium with Concomitant Administration of Inhaled Budesonide in Asthmatic Patients.
ClinicalTrials.gov Identifier: NCT00140946 - Active, not recruiting
Asthma
- TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00057720 - Active, not recruiting
Ovarian Neoplasms
- Dietary Patterns, Sodium Intake and Blood Pressure (DASH - Sodium)
ClinicalTrials.gov Identifier: NCT00000608 - Active, not recruiting
Cardiovascular Diseases; Heart Diseases; Hypertension; Vascular Diseases

Not Signed In -

